The association of CHA2DS2-VASc score and blood biomarkers with ischemic stroke outcomes: The Belgrade stroke study

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Potpara, Tatjana S ^a,b   Polovina, Marija M ^b   Djikic, Dijana ^b,c   Marinkovic, Jelena M ^a   Kocev, Nikola ^a   Lip, Gregory Y H ^a,d  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

^c UNIVERSITY CLINICAL CENTER OF KOSOVO   (Serbia)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; FIBRINOGEN; TROPONIN I;

AGED; ARTICLE; BLOOD; BRAIN ISCHEMIA; CHA2DS2 VASC SCORE; CHADS2 SCORE; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREDICTION; PROGNOSIS; SENSITIVITY AND SPECIFICITY; CEREBROVASCULAR ACCIDENT; ISCHEMIA; METABOLISM; MIDDLE AGED; PATHOLOGY; RISK FACTOR; TREATMENT OUTCOME; UNITED STATES;

AGED; C-REACTIVE PROTEIN; FEMALE; FIBRINOGEN; HUMANS; ISCHEMIA; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; STROKE; TREATMENT OUTCOME; TROPONIN I; UNITED STATES;

EID: 84906991078     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106439     Document Type: Article

References (52)

1. Weimar C, Konig IR, Kraywinkel K, Ziegler A,Diener HC; German Stroke Study Collaboration (2004) Age and National Institutes of Health Stroke Scale score within 6 hours after onset are accurate predictors of outcome after cerebral ischemia: development and external validation of prognostic models. Stroke 35:158-162.
2. Smith EE, Shobha N, Dai D, Olson DM, Reeves MJ, et al. (2010) Risk score for in-hospital ischemic stroke mortality derived and validated within the Get WithThe Guidelines- Stroke Program. Circulation 122:1496-1504.
3. Counsell C, Dennis M, McDowall M (2004) Predicting functional outcome in acute stroke: comparison of a simple six variable model with other predictive systems and informal clinical prediction. J Neurol Neurosurg Psychiatry 75:401-405.
4. Whiteley W, Chong WL, Sengupta A, Sandercock P (2009) Blood markers for the prognosis of ischemic stroke: a systematic review. Stroke 40:e380-e389.
5. Dixit S, Castle M, Velu RP, Swisher L, Hodge C, et al. (2000) Cardiac involvement in patients with acute neurologic disease: confirmation with cardiac TnI. Arch Intern Med 160:3153-3158.
6. Christensen H, Johannesen HH, Christensen AF, Bendtzen K, Boysen G (2004) Serum cardiac TnI in acute stroke is related to serum cortisol and TNF-alpha. Cerebrovasc Dis 18:194-199.
7. Di Angelantonio E, Fiorelli M, Toni D, Sacchetti ML, Lorenzano S, et al. (2005) Prognostic significance of admission levels of TnI in patients with acute ischaemic stroke. J Neurol Neurosurg Psychiatry 76:76-81.
8. James P, Ellis CJ, Whitlock RM, McNeil AR, Henley J, et al. (2000) Relation between troponin T concentration and mortality in patients presenting with an acute stroke: observational study. BMJ 320:1502-1504.
9. Jensen JK, Kristensen SR, Bak S, Atar D, Høilund-Carlsen PF, et al. (2007) Frequency and significance of troponin T elevation in acute ischemic stroke. Am J Cardiol 99:108-112.
10. Faiz KW, Thommessen B, Einvik G, Omland T, Ronning OM (2014) Prognostic value of high-sensitivity cardiac troponin T in acute ischemic stroke. J Stroke Cerebrovasc Dis 23:241:248.
11. Whiteley W, Wardlaw J, Dennis M, Lowe G, Rumley A, et al. (2012) The use of blood biomarkers to predict poor outcome after acute transient ischemic attack or ischemic stroke. Stroke 43:86-91.
12. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The Euro Heart Survey on atrial fibrillation. Chest 137:263-272.
13. 2-VASc, and long-term stroke outcome in patients without atrial fibrillation. Neurology 80:1009-1017.
14. Deguchi I, Hayashi T, Ohe Y, Kato Y, Nagoya H, et al. (2013) The CHA(2)DS(2)-VASc Score Reflects Clinical Outcomes in Nonvalvular Atrial Fibrillation Patients with an Initial Cardioembolic Stroke. J Stroke Cerebrovasc Dis 22:e343-e346.
15. Giralt-Steinhauer E, Cuadrado-Godia E, Ois Á, Jiménez-Conde J, Rodríguez-Campello A, et al. (2012) CHA(2)DS(2)-VASc score and prognosis in ischemic strokes with atrial fibrillation. J Neurol 259:745-751.
16. Easton JD, Saver JL, Albers GW, Alberts MJ, Chaturvedi S, et al. (2009) Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. Stroke 40:2276-2293.
17. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, et al. (2012) 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation∗Developed with the special contribution of the European Heart Rhythm Association. Europace 14:1385-1413.
18. Van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. (1988) Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19:604-607.
19. The Multicentre Acute Stroke Trial-Italy Group (MAST-I) (1995) Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Lancet 346:1509-1514.
20. The Multicenter Acute Stroke Trial-Europe (MAST-E) (1996) Thrombolytic therapy with streptokinase in acute ischemic stroke. N Engl J Med 335:145-150.
21. DeLong R, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837-845.
22. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS (2008) Comments on Integrated discrimination and net reclassification improvements - practical advice. Statist Med 27:207-212.
23. Olesen JB, Lip GYH, Hansen ML, Hansen PR, Tolstrup JS, et al. (2011) Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ 342-d124.
24. Van Staa TP, Setakis E, Di Tanna GL, Lane DA, Lip GYH (2011) A comparison of risk stratification schemes for stroke in 79 884 atrial fibrillation patients in general practice. J Thromb Haemost 9:39-48.
25. Olesen JB, Torp-Pedersen C, Hansen ML, Lip GY (2012) The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study. Thromb Haemost 107:1172-1179.
26. Potpara TS, Polovina MM, Licina MM, Marinkovic JM, Prostran MS, et al. (2012) Reliable identification of "truly low" thromboembolic risk in patients initially diagnosed with "lone" atrial fibrillation: the Belgrade atrial fibrillation study. Circ Arrhythm Electrophysiol 5:319-326.
27. Lip GY (2013) Stroke and bleeding risk assessment in atrial fibrillation: when, how, and why? Eur Heart J 34:1041-1049.
28. Lip GY, Lin HJ, Chien KL, Hsu HC, Su TC, et al. (2013) Comparative assessment of published atrial fibrillation stroke risk stratification schemes for predicting stroke, in a non-atrial fibrillation population: The Chin-Shan Community Cohort Study. Int J Cardiol 168:414-419.
29. Paoletti Perini A, Bartolini S, Pieragnoli P, Ricciardi G, Perrotta L, et al. (2014) CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy. Europace 16:71-80.
30. Tu HTH, Campbell BCV, Meretoja A, Churilov L, Lees KR, et al. (2013) Pre-stroke CHADS 2 and CHA2DS2 - VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation. Cerebrovasc Dis 36:273-280.
31. Lip GYH (2013) Using the CHADS 2 and CHA2DS2 -VASc Scores for Stroke Risk Prediction as well as the Identification of Stroke Outcomes and Cardiac Complications in Patients with and without Atrial Fibrillation. Cerebrovasc Dis 36:281-282.
32. Hijazi Z, Oldgren J, Siegbahn A, Granger CB, Wallentin L (2013) Biomarkers in atrial fibrillation: a clinical review. Eur Heart J 34:1475-1480.
33. Hasan N, McColqan P, Edwards RJ, Sharma P (2012) Towards the identification of blood biomarkers for acute stroke in humans: a comprehensive systematic review. Br J Clin Pharmacol 74:230-240.
34. Salat D, Penalba A, García-Berrocoso T, Campos-Martorell M, Flores A, et al. (2013) Immunological biomarkers improve the accuracy of clinical risk models of infection in the acute phase of ischemic stroke. Cerebrovasc Dis 35:220-227.
35. Montaner J, García-Berrocoso T, Mendioroz M, Palacios M, Perea-Gainza M, et al. (2012) Brain natriuretic peptide is associated with worsening and mortality in acute stroke patients but adds no prognostic value to clinical predictors of outcome. Cerebrovasc Dis 34:240-245.
36. Hijazi Z, Oldgren J, Andersson U, Connolly SJ, Ezekowitz MD, et al. (2012) Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation. A randomized evaluation of long-term anticoagulation therapy (RE-LY) substudy. Circulation 125:1605-1616.
37. Antman EM, Tanasijevic MJ, Thompson B, Schactman M, McCabe CH, et al. (1996) Cardiac-specific TnI levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 335:1342-1349.
38. Horwich TB, Patel J, MacLellan WR, Fonarow GC (2003) Cardiac TnI is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation 108:833-838.
39. Omland T, de Lemos JA, Sabatine MS, Christophi CA, Rice MM, et al. (2009) A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med 361:2538-2547.
40. Jeremias A, Gibson CM (2005) Narrative review: alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded. Ann Intern Med 142:786-791.
41. Agewall S, Giannitsis E, Jernberg T, Katus H (2011) Troponin elevation in coronary vs. non-coronary disease. Eur Heart J 32:404-411.
42. Freda BJ, Tang WHW, van Lente F, Peacock WF, Francis GS (2002) Cardiac troponins in renal insufficiency: review and clinical implications. J Am Coll Cardiol 40:2065-2071.
43. Kerr G, Ray G, Wu O, Stott DJ, Langhorne P (2009) Elevated troponin after stroke: a systematic review. Cerebrovasc Dis 28:220-226.
44. James P, Ellis CJ, Whitlock RM, McNeil AR, Henley J, et al. (2000) Relation between troponin T concentration and mortality in patients presenting with an acute stroke: observational study. BMJ 320:1502-1504.
45. Di Angelantonio E, Fiorelli M, Toni D, Sacchetti ML, Lorenzano S, et al. (2005) Prognostic significance of admission levels of TnI in patients with acute ischaemic stroke. J Neurol Neurosurg Psychiatr 76:76-81.
46. Jensen JK, Kristensen SR, Bak S, Atar D, Høilund-Carlsen PF, et al. (2007) Frequency and significance of troponin T elevation in acute ischemic stroke. Am J Cardiol 99:108-112.
47. Ay H, Koroshetz WJ, Benner T, Vangel MG, Melinosky C, et al. (2006) Neuroanatomic correlates of strokerelated myocardial injury. Neurology 66:1325-1329.
48. Mahajan VS, Jarolim P (2011) How to interpret elevated cardiac troponin levels. Circulation 124:2350-2354.
49. Scheitz JF, Mochmann HC, Nolte CH, Haeusler KG, Audebert HJ, et al. (2011) Troponin elevation in acute ischemic stroke (TRELAS) - protocol of a prospective observational trial. BMC Neurology 11:98.
50. Fonarow GC, Pan W, Saver JL, Smith EE, Reeves MJ, et al. (2012) Comparison of 30-day mortality models for profiling hospital performance in acute ischemic stroke with vs without adjustment for stroke severity. JAMA 308:257-264.
51. Heuschmann PU, Kolominsky-Rabas PL, Misselwitz B, Hermanek P, Leffmann C, et al. (2004) Predictors of in-hospital mortality and attributable risk of death after ischemic stroke: the German Stroke Registers Study Group. Arch Intern Med 164:1761-1768.
52. Smith EE, Shobha N, Dai D, Olson DM, Reeves MJ, et al. (2010) Risk score for in-hospital ischemic stroke mortality derived and validated within the Get With The Guidelines- Stroke Program. Circulation 122:1496-1504.